Phreesia, INC

Market Movers (8-K)

NYSE
Phreesia, Inc. stockholders re-elected directors, ratified auditors, and approved executive compensation at the 2026 annual meeting.
NYSE
Phreesia, Inc. announced robust first-quarter fiscal 2027 financial results, showcasing significant year-over-year growth in revenue, net income, and adjusted EBITDA.
NYSE
Phreesia, Inc. has implemented a restructuring plan to reduce operating expenses, including the elimination of approximately 220 positions.
NYSE
Phreesia, Inc. announced an amendment to its receivables purchase agreement, increasing the facility limit to $300 million and extending the termination date to April 30, 2029.
NYSE
Phreesia announces positive GAAP net income and record free cash flow for FY2026, while revising FY2027 revenue guidance downwards due to shorter visibility in network solutions.
Delay expected
NYSE
Phreesia, Inc. secured a new $275 million revolving credit facility, replacing its existing bridge loan and asset-based facility, enhancing financial flexibility and reducing borrowing costs.
Capital raise

Quarterly Earnings (10-Q)

NYSE
Phreesia reports a significant turnaround to net income in Q3 2025, driven by strong revenue growth across all segments and the strategic acquisition of AccessOne.
Better than expected
Capital raise
NYSE
Phreesia, Inc. announced robust financial results for the second quarter, achieving net income and significant growth in revenue and Adjusted EBITDA, alongside a strategic acquisition.
Better than expected
Capital raise
NYSE
Phreesia, Inc. announced a substantial reduction in net loss and a significant increase in Adjusted EBITDA and free cash flow for the first quarter ended April 30, 2025, driven by robust revenue growth across all segments.
Better than expected
NYSE
Phreesia Inc. saw a 17% increase in total revenue for the third quarter of fiscal year 2025, reaching $106.8 million, despite challenges in payment processing.
Better than expected
Delay expected
NYSE
Phreesia Inc. saw a 19% increase in revenue and a significant reduction in net loss for the second quarter of fiscal year 2025, according to its latest 10-Q filing.
Better than expected
Delay expected
NYSE
Phreesia Inc. saw a 21% increase in revenue in Q1 2025, reaching $101.2 million, despite facing headwinds from cybersecurity incidents.
Better than expected
Delay expected

Annual Reports (10-K)

NYSE
Phreesia reported a significant turnaround to net income of $2.3 million in fiscal year 2026, up from a $58.5 million net loss in the prior year, fueled by strong revenue growth across all segments and the strategic AccessOne acquisition.
Better than expected
Capital raise
Delay expected
NYSE
Phreesia, a healthcare software solutions provider, announced an 18% increase in total revenue for fiscal year 2025, reaching $419.8 million, and a shift to positive adjusted EBITDA of $36.8 million.
Delay expected
Better than expected
NYSE
Phreesia Inc.'s 10-K filing reveals a 27% revenue increase to $356.3 million for fiscal year 2024, alongside strategic acquisitions and a focus on margin enhancement.
Better than expected
Capital raise

Insider Trading (Form 4)

NYSE
Lainie Goldstein, a Director of Phreesia, Inc., received 377 shares of common stock on July 31, 2026.
NYSE
David Linetsky, President, Network Solutions of Phreesia, Inc., reported a transaction in 69 shares of common stock on July 15, 2026.
NYSE
Yvonne Hui, Principal Accounting Officer of Phreesia, Inc., sold 1,247 shares of common stock on July 15, 2026 for $10.92 per share.
NYSE
Lisa Egbuonu-Davis, a Director of Phreesia, Inc., sold 536 shares of common stock on July 14, 2026 for $10.70 per share.
NYSE
Yvonne Hui, Principal Accounting Officer at Phreesia, Inc., reported a sale of 1,371 shares of common stock executed on July 6, 2026, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
Phreesia's General Counsel & Secretary, Allison C. Hoffman, acquired 1,265 shares of common stock through the company's Employee Stock Purchase Plan.

Proxy Statements (Def-14A)

NYSE
Phreesia, Inc. invites stockholders to its 2026 Annual Meeting on June 24, 2026, to elect directors, ratify auditor appointment, and vote on executive compensation.
NYSE
Phreesia, Inc. has filed a definitive proxy statement with the SEC.
NYSE
Phreesia, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 25, 2025, to elect directors, ratify the appointment of KPMG LLP, and approve executive compensation.
NYSE
Phreesia, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
Phreesia, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 26, 2024, to vote on the election of directors, ratification of the independent auditor, and executive compensation.
Worse than expected

Schedule 13D - Activist Investments

NYSE
Pale Fire Capital SICAV a.s. has increased its stake in Phreesia, Inc. by acquiring additional shares.
NYSE
Pale Fire Capital and its affiliates have increased their beneficial ownership in Phreesia, Inc. to 12.7% of outstanding common stock, totaling 7,648,829 shares.
NYSE
Pale Fire Capital and its affiliates have acquired a 9.2% stake in Phreesia, Inc., believing the shares were undervalued and represent an attractive investment opportunity.

Schedule 13G - Passive Investments

NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.77% of Phreesia Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting a 0% beneficial ownership in Phreesia Inc. following an internal corporate realignment.
NYSE
Greenhouse Funds LLLP and its affiliates have filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in PHREESIA, INC. as of December 31, 2025.
NYSE
Capital International Investors has reported reducing its beneficial ownership in Phreesia, Inc. to 4.7% of common stock, falling below the 5% threshold.
NYSE
The Vanguard Group filed an amended Schedule 13G, disclosing a 10.09% beneficial ownership stake in Phreesia Inc. common stock.
NYSE
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, disclosing a beneficial ownership of 0.6% of Phreesia Inc.'s common stock as of December 31, 2025.